Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of different doses of ZD2202 for postoperative analgesia after abdominal surgery
CTR20263549Phase 2Active
- Sponsor
- Zhejiang Zhida Pharmaceutical
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZD2202 in postoperative pain, sponsored by Zhejiang Zhida Pharmaceutical. Started Sep 2026; status: active.
02
Drugs
ZD2202
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20263549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263549.